• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管加压素V1b受体激动剂结合与内化过程中的联合钠离子敏感性

Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors.

作者信息

Koshimizu Taka-Aki, Kashiwazaki Aki, Taniguchi Junichi

机构信息

Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi 329-0498, Japan.

出版信息

Sci Rep. 2016 May 3;6:25327. doi: 10.1038/srep25327.

DOI:10.1038/srep25327
PMID:27138239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4853784/
Abstract

Reducing Na(+) in the extracellular environment may lead to two beneficial effects for increasing agonist binding to cell surface G-protein coupled receptors (GPCRs): reduction of Na(+)-mediated binding block and reduce of receptor internalization. However, such combined effects have not been explored. We used Chinese Hamster Ovary cells expressing vasopressin V1b receptors as a model to explore Na(+) sensitivity in agonist binding and receptor internalization. Under basal conditions, a large fraction of V1b receptors is located intracellularly, and a small fraction is in the plasma membrane. Decreases in external Na(+) increased cell surface [(3)H]AVP binding and decreased receptor internalization. Substitution of Na(+) by Cs(+) or NH4(+) inhibited agonist binding. To suppress receptor internalization, the concentration of NaCl, but not of CsCl, had to be less than 50 mM, due to the high sensitivity of the internalization machinery to Na(+) over Cs(+). Iso-osmotic supplementation of glucose or NH4Cl maintained internalization of the V1b receptor, even in a low-NaCl environment. Moreover, iodide ions, which acted as a counter anion, inhibited V1b agonist binding. In summary, we found external ionic conditions that could increase the presence of high-affinity state receptors at the cell surface with minimum internalization during agonist stimulations.

摘要

降低细胞外环境中的Na⁺可能会对增加激动剂与细胞表面G蛋白偶联受体(GPCRs)的结合产生两种有益效果:减少Na⁺介导的结合阻滞以及减少受体内化。然而,尚未对这种联合效应进行探索。我们使用表达血管加压素V1b受体的中国仓鼠卵巢细胞作为模型,来探究激动剂结合和受体内化过程中的Na⁺敏感性。在基础条件下,大部分V1b受体位于细胞内,小部分位于质膜中。细胞外Na⁺的减少增加了细胞表面[³H]AVP的结合,并减少了受体内化。用Cs⁺或NH₄⁺替代Na⁺会抑制激动剂结合。为了抑制受体内化,由于内化机制对Na⁺的敏感性高于Cs⁺,NaCl的浓度必须低于50 mM,而CsCl则不必。即使在低NaCl环境中,等渗补充葡萄糖或NH₄Cl也能维持V1b受体的内化。此外,作为抗衡阴离子的碘离子会抑制V1b激动剂的结合。总之,我们发现了外部离子条件,这些条件可以在激动剂刺激期间以最小的内化增加细胞表面高亲和力状态受体的存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/b08e9d922769/srep25327-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/b1bb85559034/srep25327-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/bccc79b3c9cc/srep25327-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/62c3bd596fa1/srep25327-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/708059569899/srep25327-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/7b185c54db21/srep25327-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/3d4910d2ed71/srep25327-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/b08e9d922769/srep25327-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/b1bb85559034/srep25327-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/bccc79b3c9cc/srep25327-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/62c3bd596fa1/srep25327-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/708059569899/srep25327-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/7b185c54db21/srep25327-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/3d4910d2ed71/srep25327-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a950/4853784/b08e9d922769/srep25327-f7.jpg

相似文献

1
Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors.血管加压素V1b受体激动剂结合与内化过程中的联合钠离子敏感性
Sci Rep. 2016 May 3;6:25327. doi: 10.1038/srep25327.
2
Subcellular localization and internalization of the vasopressin V1B receptor.血管加压素 V1B 受体的亚细胞定位和内化。
Eur J Pharmacol. 2015 Oct 15;765:291-9. doi: 10.1016/j.ejphar.2015.08.043. Epub 2015 Aug 28.
3
[1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.[1-脱氨基-4-环己基丙氨酸]精氨酸加压素:一种强效且特异性的血管加压素V1b受体激动剂。
Endocrinology. 2002 Dec;143(12):4655-64. doi: 10.1210/en.2002-220363.
4
Mapping the binding site of arginine vasopressin to V1a and V1b vasopressin receptors.精氨酸加压素与V1a和V1b加压素受体结合位点的定位
Mol Endocrinol. 2007 Feb;21(2):512-23. doi: 10.1210/me.2006-0202. Epub 2006 Nov 2.
5
Neuroanatomical distribution and function of the vasopressin V receptor in the rat brain deciphered using specific fluorescent ligands.利用特异性荧光配体解析大鼠脑中血管加压素V受体的神经解剖分布及功能。
Gen Comp Endocrinol. 2018 Mar 1;258:15-32. doi: 10.1016/j.ygcen.2017.10.011. Epub 2017 Nov 17.
6
Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.血管加压素通过V1b受体刺激胰岛细胞释放胰岛素:药理学与基因敲除相结合的研究方法
Mol Pharmacol. 2004 Mar;65(3):623-9. doi: 10.1124/mol.65.3.623.
7
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.大鼠血管加压素V(1b)受体首个选择性激动剂的设计与合成:基于脱氨基-[半胱氨酸1]精氨酸血管加压素4位和8位的修饰
J Med Chem. 2007 Feb 22;50(4):835-47. doi: 10.1021/jm060928n.
8
Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas.胰腺血管加压素V1b受体:在In-R1-G9细胞中的特性及在人胰腺中的定位
Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E566-76. doi: 10.1152/ajpendo.00148.2003. Epub 2003 May 7.
9
AVP-induced mitogenic responses of Chinese hamster ovary cells expressing human V1A or V1B receptors.
Pflugers Arch. 1999 Jan;437(2):219-26. doi: 10.1007/s004240050772.
10
Differential coupling of the vasopressin V1b receptor through compartmentalization within the plasma membrane.通过质膜内的区室化实现血管加压素V1b受体的差异偶联。
Mol Pharmacol. 2009 Mar;75(3):637-47. doi: 10.1124/mol.108.049031. Epub 2008 Dec 1.

引用本文的文献

1
Harnessing Ion-Binding Sites for GPCR Pharmacology.利用离子结合位点研究 G 蛋白偶联受体药理学。
Pharmacol Rev. 2019 Oct;71(4):571-595. doi: 10.1124/pr.119.017863.

本文引用的文献

1
Subcellular localization and internalization of the vasopressin V1B receptor.血管加压素 V1B 受体的亚细胞定位和内化。
Eur J Pharmacol. 2015 Oct 15;765:291-9. doi: 10.1016/j.ejphar.2015.08.043. Epub 2015 Aug 28.
2
Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide.
Eur J Pharmacol. 2015 Feb 15;749:98-106. doi: 10.1016/j.ejphar.2015.01.001. Epub 2015 Jan 12.
3
Allosteric sodium in class A GPCR signaling.A类G蛋白偶联受体信号传导中的变构钠
Trends Biochem Sci. 2014 May;39(5):233-44. doi: 10.1016/j.tibs.2014.03.002. Epub 2014 Apr 21.
4
The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.肾脏和肾外血管加压素 V2 受体的生理和病理生理功能。
Am J Physiol Renal Physiol. 2014 May 1;306(9):F931-40. doi: 10.1152/ajprenal.00604.2013. Epub 2014 Mar 5.
5
High- and low-affinity sites for sodium in δ-OR-Gi1α (Cys (351)-Ile (351)) fusion protein stably expressed in HEK293 cells; functional significance and correlation with biophysical state of plasma membrane.高亲和和低亲和钠离子结合位点在 δ-OR-Gi1α(Cys(351)-Ile(351))融合蛋白中的表达及其与质膜生物物理状态的功能相关性。该融合蛋白稳定表达于 HEK293 细胞中。
Naunyn Schmiedebergs Arch Pharmacol. 2014 May;387(5):487-502. doi: 10.1007/s00210-014-0962-8. Epub 2014 Mar 1.
6
Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.转铁蛋白受体介导的内吞作用:癌症治疗的一个有用靶点。
J Membr Biol. 2014 Apr;247(4):291-307. doi: 10.1007/s00232-014-9637-0. Epub 2014 Feb 27.
7
The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor.钠离子结合位点在 A(2A)腺苷 G 蛋白偶联受体变构调节中的作用。
Structure. 2013 Dec 3;21(12):2175-85. doi: 10.1016/j.str.2013.09.020. Epub 2013 Nov 7.
8
Search for inhibitors of endocytosis: Intended specificity and unintended consequences.寻找内吞作用抑制剂:预期特异性和非预期后果。
Cell Logist. 2012 Oct 1;2(4):203-208. doi: 10.4161/cl.23967.
9
Vasopressin V1a and V1b receptors: from molecules to physiological systems.血管加压素 V1a 和 V1b 受体:从分子到生理系统。
Physiol Rev. 2012 Oct;92(4):1813-64. doi: 10.1152/physrev.00035.2011.
10
Restructuring G-protein- coupled receptor activation.重构 G 蛋白偶联受体激活。
Cell. 2012 Sep 28;151(1):14-23. doi: 10.1016/j.cell.2012.09.003.